FDA approves eyeglass lenses to slow nearsightedness in children

The FDA has authorized the first eyeglass lenses in the U.S. designed to slow the progression of nearsightedness in children. Essilor's Stellest lenses are now available for children aged 6-12 with myopia, offering a lower-risk alternative to existing treatments like contact lenses. Clinical trials showed these lenses slowed myopia progression by 71% on average, potentially reducing the risk of severe vision issues later in life.